• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Gilead Sciences to Acquire Arcellx

    BUSINESSWIRE

    Arcellx To Discuss Early CAR T Access For Multiple Myeloma

    BUSINESSWIRE

    Arcellx Reveals Positive Results In iMMagine-1 Study in Myeloma

    BUSINESSWIRE

    Arcellx Hosts IR Event at 67th ASH Annual Meeting

    BUSINESSWIRE

    J&J, Legend Pull ASH Paper Comparing Carvykti Against Rival CAR-T

    FIERCE PHARMA

    Arcellx Provides Third Quarter 2025 Financial Results

    BUSINESS WIRE

    Gilead And Kite Show Progress In Blood Cancer Cell Therapy Data

    BUSINESSWIRE

    Arcellx Showcases Immagine-1 Study Data at ASH Conference

    BUSINESSWIRE

    Arcellx to Present at 2025 Morgan Stanley Healthcare Conference

    PHARMAWEB

    Arcellx to Participate in TD Cowen`s Oncology Summit and EHA2025

    BUSINESSWIRE

    Arcellx Reports Q1 2025 Financials and Business Highlights

    BUSINESSWIRE

    Arcellx Releases Q4 & Year-End 2024 Financial Highlights

    BUSINESSWIRE

    Arcellx To Present At TD Cowen Annual Health Care Conference

    BUSINESSWIRE

    Arcellx Provides Q3 2024 Financial Results & Business Highlights

    BUSINESSWIRE

    Arcellx to Present Data for Ph 1 Study in Multiple Myeloma at ASH

    BUSINESSWIRE

    Arcellx Provides Second Quarter 2024 Financial Results and Business Updates

    BUSINESSWIRE

    Arcellx Announces Continued Responses from Its CART-ddBCMA Phase 1 Trial

    PR NEWSWIRE

    Arcellx Announces Oral Presentation for Its CART-ddBCMA Phase 1 Trial

    PR NEWSWIRE

    Kite And Arcellx Close Agreement To Co-Develop CART-DdBCMA In Multiple Myeloma

    PRESS RELEASE

    Kite and Arcellx partner to advance blood cancer cell therapy

    BIOPROCESSINTL

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.